Pathophysiology

doi: 10.25005/2074-0581-2023-25-4-499-508
EVALUATION OF HEMATOTOXICITY OF NEW DERIVATIVES OF CONDENSED 3-AMINOTHIENO[2,3-b]PYRIDINES AND 1,4-DIHYDROPYRIDINES WITH HIGH ANALGESIC ACTIVITY

I.V. BIBIK1, A.A. PANKOV2, K.A. FROLOV2, V.V. DOTSENKO3,4, S.G. KRIVOKOLYSKO1,2, E.YU. BIBIK1

1Lugansk State Medical University named after St. Luke, Lugansk, Russian Federation
2Lugansk State University named after Vladimir Dal, Lugansk, Russian Federation
3Kuban State University, Krasnodar, Russian Federation
4North Caucasus Federal University, Stavropol, Russian Federation

Objective: To assess changes in blood parameters in rats after a two-week administration of the most commonly used clinically NSAIDs and new derivatives of the 3-aminothieno[2,3-b]pyridine and 1,4-dihydronicotinamide series with the most pronounced analgesic activity.

Methods: Ten low molecular weight ligands were chosen after screening various ligands. These ligands are capable of interacting with receptors and enzymes that are involved in the antinociceptive system. They contain fragments of 3-aminothieno[2,3-b]pyridine and 1,4-dihydronicotinamide. Samples with laboratory codes AZ023, AZ169, AZ213, AZ257, AZ729, AZ383, AZ331, AZ420, AU04271, AU04288 were selected for the experiment. Among them, AZ383, AZ331, AZ023, and AZ420 were chosen. The study involved 36 white male rats weighing between 250-280 g. Blood was collected via the femoral vein and analyzed using standard methods for erythrocyte, leukocyte, platelet, hemoglobin, and erythrocyte sedimentation rate (ESR) levels.

Results: According to experimental studies, unlike the reference drug, the compounds studied do not cause leukopenia. In addition, only a tendency to decrease the number of platelets was detected for compounds AZ023, AZ331, and AZ383 with pronounced analgesic and anti-inflammatory activity, which requires additional research.

Conclusion: Studies conducted on the safety of using derivatives of condensed 3-aminothieno[2,3-b]pyridines and 1,4-dihydropyridines have shown promising results for further preclinical development. These derivatives can become highly effective and safe agents for alleviating pain and inflammation of various origins and severity in the future.

Keywords: Blood test, hematotoxicity, pain syndrome, analgesic activity, thienopyridines, 1,4-dihydropyridines.

Download file:


References
  1. Pakhomova IG, Kuchmin AN, Pavlova EYu. Nesteroidnye protivovospalitel'nye preparaty pri ostroy boli: konsensus effektivnosti i bezopasnosti [Nonsteroidal anti-inflammatory drugs for acute pain: Consensus of efficacy and safety]. Russkiy meditsinskiy zhurnal. 2017;21:1537-42.
  2. Al B, Sunar MM, Zengin S, Sabak M, Bogan M, Can B, et al. Comparison of IV dexketoprofen trometamol, fentanyl, and paracetamol in the treatment of renal colic in the ED: A randomized controlled trial. American Journal of Emergency Medicine. 2018;36(4):571-6. https://doi.org/10.1016/j.ajem.2017.09.019
  3. Sosnov AV, Semchenko FM, Vlasov MI, Tokhmakhchi VN, Sosnova AA. Razvitie kompleksnoy farmakoterapii sil'noy i sredney boli. Chast' 1. Mul'titargetnoe kombinirovanie opioidov i nenarkoticheskikh anal'getikov tsentral'nogo deystviya [Development of complex pharmacotherapy of severe and moderate pain. Part 1. Multi-target combination of opioids and non-narcotic analgesics of central action]. Razrabotka i registratsiya lekarstvennykh sredstv. 2017;2:176-87.
  4. Zotov PB. Sistemnaya farmakoterapiya khronicheskogo bolevogo sindroma pri rasprostranyonnom rake u bol'nykh pozhilogo vozrasta [Systemic pharmacotherapy of chronic pain syndrome in advanced cancer in elderly patients]. Nauchnyy forum. Sibir'. 2016;2(2):56-63.
  5. Olry de Labry Lima A, Salamanca-Fernández E, Alegre Del Rey EJ, Matas Hoces A, González Vera MÁ, Bermúdez Tamayo C. Safety considerations during prescription of non-steroidal anti-inflammatory drugs (NSAIDs), through a review of systematic reviews. An Sist Sanit Navar. 2020;44(2):261-73. https://doi. org/10.23938/ASSN.0965
  6. Melnik MG. Vybor optimal'nogo nesteroidnogo protivovospalitel'nogo preparata s pozitsii kardiologa [Choosing the optimal nonsteroidal anti-inflammatory drug from the perspective of a cardiologist]. Meditsinskiy alfavit. 2020;36:55- 60. https://doi.org/10.33667/2078-5631-2020-36-55-60
  7. Sarmanaeva RR, Abuzarova GR, Bychkova NV, Alekseeva GS. Lechenie variativnogo bolevogo sindroma pri luchevoy terapii kostnykh metastazov raka molochnoy zhelezy [Treatment of variable pain syndrome during radiation therapy of bone metastases of breast cancer.] Meditsinskiy sovet. 2019;19:165-8. https://doi.org/10.21518/2079-701X-2019-19-165-168
  8. Chichasova NV. Problema otsenki effektivnosti i bezopasnosti nesteroidnykh protivovospalitel'nykh preparatov [The problem of evaluating the effectiveness and safety of nonsteroidal anti-inflammatory drugs]. Sovremennaya revmatologiya. 2016;2:83-6. https://doi.org/10.14412/1996-7012-2016-2-83-88
  9. Zholobova ES, Konopelko OYu, Gesheva ZV. Gepatotoksichnost' nesteroidnykh protivovospalitel'nykh preparatov, primenyaemykh v detskoy revmatologii [Hepatotoxicity of nonsteroidal anti-inflammatory drugs used in pediatric rheumatology.] Pediatriya. Zhurnal im. G. N. Speranskogo. 2009;5:154-9.
  10. Ravikumar B, Aittokallio T. Improving the efficacy-safety balance of polypharmacology in multi-target drug discovery. Exp Opin Drug Discov. 2018;13(2):179. https://doi.org/10.1080/17460441.2018.1413089
  11. Yet L. Privileged structures in drug discovery: Medicinal chemistry and synthesis. Hoboken, NJ: Wiley; 2018. 560 р.
  12. Krivokolysko DS, Dotsenko VV, Bibik EYu. New 4-(2-Furyl)-1,4-dihydronicotinonitriles and 1,4,5,6-tetrahydronicotinonitriles: Synthesis, structure, and analgesic activity. Russian Journal of General Chemistry. 2021;91(9):1646-60. https:// doi.org/10.1134/S1070363221090073
  13. Dotsenko VV, Buryi DS, Lukina DYu, Krivokolysko SG. Recent advances in the chemistry of thieno[2,3-b]pyridines 1. Methods of synthesis of thieno[2,3-b] pyridines. Russian Chemical Bulletin. 2020;69(10):1829-58. https://doi. org/10.1007/s11172-020-2969-2
  14. Bibik IV, Bibik EY, Dotsenko VV, Frolov KA, Krivokolysko SG. Synthesis and analgesic activity of new heterocyclic cyanothioacetamide derivatives. Russian Journal of General Chemistry. 2021;91(2):154-66. https://doi.org/10.1134/ S107036322102002X
  15. Khan MM, Khan S, Iqbal S. Recent developments in multicomponent synthesis of structurally diversified tetrahydropyridines. RSC Adv. 2016;6(48):42045-61. https://doi.org/10.1039/c6ra06767k
  16. Gfeller D, Michielin O, Zoite V. Shaping the interaction landscape of bioactive molecules. Bioinformatics. 2013;29(23):3073-9. https://doi.org/10.1093/bioinformatics/btt540
  17. Cheng F, Li W, Zhou Y, Shen J, Wu Z, Liu G, et al. AdmetSAR: A comprehensive source and free tool for assessment of chemical ADMET properties. J Chem Inf Model. 2012;52(11):3099-105. https://doi.org/10.1021/ci300367a
  18. Bibik IV, Bibik EYu, Pankov AA, Frolov KA, Dotsenko VV, Krivokolysko SG. Issledovanie protivovospalitel'nykh i antinotsitseptivnykh svoystv novykh proizvodnykh kondensirovannykh 3-aminotieno[2,3-b]piridinov i 1,4-digidropiridinov [Study of anti-inflammatory and antinociceptive properties of new derivatives of condensed 3-aminothieno[2,3-b]pyridines and 1,4-dihydropyridines]. Acta Biomedica Scientifica. 2023;8(4):220-34. https://doi.org/10.29413/ABS.2023- 8.4.24

Authors' information:


Bibik Igor Valerievich,
Candidate of Medical Sciences, Associate Professor of the Department of Surgical Dentistry, Lugansk State Medical University named after St. Luke
ORСID ID: 0000-0003-4053-1431
E-mail: dr.bibik.i.v@yandex.ru.

Pankov Andrey Aleksandrovich,
Doctor of Technical Sciences, Professor of the Department of Transport Technologies, Lugansk State University named after Vladimir Dal
ORCID ID: 0000-0003-2813-8231
E-mail: app.post@rambler.ru

Frolov Konstantin Aleksandrovich,
Candidate of Chemical Sciences, Associate Professor of the Department of Pharmaceutical Chemistry and Pharmacognosy, Lugansk State Medical University named after St. Luke; Chief Engineer of the Research Laboratory "СhemEx", Lugansk State University named after Vladimir Dal
ORCID ID: 0000-0002-8045-7582
E-mail: ka.frolov@inbox.ru

Dotsenko Viktor Viktorovich,
Doctor of Chemical Sciences, Head of Department of Organic Chemistry and Technologies, Kuban State University; Senior Researcher of the Research Laboratory "СhemEx", Lugansk State University named after Vladimir Dal; Senior Researcher of the Department of Organic Chemistry, North Caucasus Federal University
ORCID ID: 0000-0001-7163-0497
E-mail: victor_dotsenko_@mail.ru

Krivokolysko Sergey Gennadievich,
Doctor of Chemical Sciences, Head of the Department of Pharmaceutical Chemistry and Pharmacognosy, Lugansk State Medical University named after St. Luke; Head of the Research Laboratory "СhemEx", Lugansk State University named after Vladimir Dal
ORCID ID: 0000-0001-9879-9217
E-mail: ksg-group-lugansk@mail.ru

Bibik Elena Yurievna,
Doctor of Medical Sciences, Head of the Department of Fundamental and Clinical Pharmacology, Lugansk State Medical University named after St. Luke
ORCID ID: 0000-0002-2622-186X
E-mail: helen_bibik@mail.ru

Information about support in the form of grants, equipment, medications

The authors did not receive financial support from manufacturers of medicines and medical equipment

Conflicts of interest: No conflict

Address for correspondence:


Bibik Elena Yurievna
Doctor of Medical Sciences, Head of the Department of Fundamental and Clinical Pharmacology, Lugansk State Medical University named after St. Luke

291045, Russian Federation, Lugansk, sq. 50th Anniversary of the Defense of Lugansk, 1g

Tel.: +7 (8572) 022347113

E-mail: helen_bibik@mail.ru

Materials on the topic: